Researchers show xCT protein is key link in inhibiting pancreatic cancer growth and limiting mood disturbances

by Vrije Universiteit BrusselCredit: Pixabay/CC0 Public DomainThe xCT protein, which plays an important role as a transport molecule in cells, could play a part in cancer treatment in the future, rese

Updated on: March 28,2024

Researchers show xCT protein is key link in inhibiting pancreatic cancer growth and limiting mood disturbances

by Vrije Universiteit BrusselCredit: Pixabay/CC0 Public DomainThe xCT protein, which plays an important role as a transport molecule in cells, could play a part in cancer treatment in the future, rese

Updated on:March 28,2024

Blood cancer discovery identifies high-risk patients, could improve outcomes

by Josh Barney,University of VirginiaUVA researchers say a new method of identifying acute myeloid leukemia patients likely to have a poor outcomes could eventually lead to improved treatment pl

Updated on: March 05,2024

Blood cancer discovery identifies high-risk patients, could improve outcomes

by Josh Barney,University of VirginiaUVA researchers say a new method of identifying acute myeloid leukemia patients likely to have a poor outcomes could eventually lead to improved treatment pl

Updated on:March 05,2024

New machine-learning method may aid personalized cancer therapy

byJohns Hopkins University School of MedicineExperimental procedure. The procedure includes presentation training, immunogenicity transfer learning and independent evaluation on multiple dataset

Updated on: January 11,2024

New machine-learning method may aid personalized cancer therapy

byJohns Hopkins University School of MedicineExperimental procedure. The procedure includes presentation training, immunogenicity transfer learning and independent evaluation on multiple dataset

Updated on:January 11,2024

ASCO: low-dose chemo benefits advanced gastroesophageal cancer

(HealthDay)—For frail and elderly patients with advanced gastroesophageal cancer (aGOAC), low-dose chemotherapy is noninferior to high-dose chemotherapy for progression-free survival, according to a s

Updated on: March 30,2024

ASCO: low-dose chemo benefits advanced gastroesophageal cancer

(HealthDay)—For frail and elderly patients with advanced gastroesophageal cancer (aGOAC), low-dose chemotherapy is noninferior to high-dose chemotherapy for progression-free survival, according to a s

Updated on:March 30,2024

Scientists create cost-effective, easy-to-use test to categorize a child's cancer and guide better treatment

bySt. Jude Children's Research Hospital(L to R) Co-corresponding author Jeff Klco, MD, PhD, St. Jude Department of Pathology, co-corresponding author Xiaotu Ma, PhD, St. Jude Department of C

Updated on: August 28,2024

Scientists create cost-effective, easy-to-use test to categorize a child's cancer and guide better treatment

bySt. Jude Children's Research Hospital(L to R) Co-corresponding author Jeff Klco, MD, PhD, St. Jude Department of Pathology, co-corresponding author Xiaotu Ma, PhD, St. Jude Department of C

Updated on:August 28,2024

Combo immunotherapy produces distinct waves of cancer-fighting T cells with each dose

byPerelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainA new tool for monitoring immune health patterns over time has revealed how a pair of checkpoint inhibitor

Updated on: September 07,2024

Combo immunotherapy produces distinct waves of cancer-fighting T cells with each dose

byPerelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainA new tool for monitoring immune health patterns over time has revealed how a pair of checkpoint inhibitor

Updated on:September 07,2024

Effectiveness of a new bladder cancer treatment demonstrated

by IMIM (Hospital del Mar Medical Research Institute)Credit: IMIMResearchers from the Molecular Cancer group at the Hospital del Mar Medical Research Institute (IMIM) and doctors from Hospital del Mar

Updated on: May 17,2024

Effectiveness of a new bladder cancer treatment demonstrated

by IMIM (Hospital del Mar Medical Research Institute)Credit: IMIMResearchers from the Molecular Cancer group at the Hospital del Mar Medical Research Institute (IMIM) and doctors from Hospital del Mar

Updated on:May 17,2024

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d

Updated on: March 30,2024

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d

Updated on:March 30,2024

Novel PET radiotracer successfully detects multiple cancers, offers potential for new targeted radionuclide therapy

by Society of Nuclear Medicine and Molecular ImagingMaximum-intensity projection images of 18F-fluorodeoxyglucose (FDG), 68Ga-FAP-2286, and 68Ga-FAPI-46 PET/CT imaging in seven patients with different

Updated on: January 15,2024

Novel PET radiotracer successfully detects multiple cancers, offers potential for new targeted radionuclide therapy

by Society of Nuclear Medicine and Molecular ImagingMaximum-intensity projection images of 18F-fluorodeoxyglucose (FDG), 68Ga-FAP-2286, and 68Ga-FAPI-46 PET/CT imaging in seven patients with different

Updated on:January 15,2024

Research offers insight into improving efficacy of PD-L1 immunotherapy for cancer patients

by CU Anschutz Medical CampusPD-L1 interactome graphic. Credit: CU Anschutz Medical CampusA new study published in theJNCI: Journal of the National Cancer Institutebrings researchers

Updated on: January 30,2024

Research offers insight into improving efficacy of PD-L1 immunotherapy for cancer patients

by CU Anschutz Medical CampusPD-L1 interactome graphic. Credit: CU Anschutz Medical CampusA new study published in theJNCI: Journal of the National Cancer Institutebrings researchers

Updated on:January 30,2024

Study supports germline testing for all metastatic breast cancer patients

by Tom Wilemon,Vanderbilt University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image c

Updated on: May 25,2024

Study supports germline testing for all metastatic breast cancer patients

by Tom Wilemon,Vanderbilt University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image c

Updated on:May 25,2024

Neutrophil PAD4: How does it function in cancer beyond promoting NETosis?

by Impact Journals LLCMechanisms involved in regulation of tumor progression by neutrophil PAD4. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28369A new editorial paper titled "N

Updated on: April 09,2024

Neutrophil PAD4: How does it function in cancer beyond promoting NETosis?

by Impact Journals LLCMechanisms involved in regulation of tumor progression by neutrophil PAD4. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28369A new editorial paper titled "N

Updated on:April 09,2024